Drugs used to modify the immune response in solid organ transplantation or autoimmune disease may cause dose-related nephrotoxicity. Cyclosporine, FK506, cyclosporine G, and rapamycin have all been studied experimentally and to a more limited extent in patients. This paper summarizes this literature using data from clinically relevant animal models.
|Original language||English (US)|
|Number of pages||7|
|Journal||Mineral and Electrolyte Metabolism|
|State||Published - 1994|
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism